These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 22869732)

  • 21. CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair.
    Hilmi K; Jangal M; Marques M; Zhao T; Saad A; Zhang C; Luo VM; Syme A; Rejon C; Yu Z; Krum A; Fabian MR; Richard S; Alaoui-Jamali M; Orthwein A; McCaffrey L; Witcher M
    Sci Adv; 2017 May; 3(5):e1601898. PubMed ID: 28560323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining.
    Beckta JM; Dever SM; Gnawali N; Khalil A; Sule A; Golding SE; Rosenberg E; Narayanan A; Kehn-Hall K; Xu B; Povirk LF; Valerie K
    Oncotarget; 2015 Sep; 6(29):27674-87. PubMed ID: 26320175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells.
    Hirakawa H; Fujisawa H; Masaoka A; Noguchi M; Hirayama R; Takahashi M; Fujimori A; Okayasu R
    Cancer Med; 2015 Mar; 4(3):426-36. PubMed ID: 25582113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of repair pathway choice at two-ended DNA double-strand breaks.
    Shibata A
    Mutat Res; 2017 Oct; 803-805():51-55. PubMed ID: 28781144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRCA1 promotes unloading of the CMG helicase from a stalled DNA replication fork.
    Long DT; Joukov V; Budzowska M; Walter JC
    Mol Cell; 2014 Oct; 56(1):174-85. PubMed ID: 25219499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamin-A interacting protein Hsp90 is required for DNA damage repair and chemoresistance of ovarian cancer cells.
    Wang Y; Chen Q; Wu D; Chen Q; Gong G; He L; Wu X
    Cell Death Dis; 2021 Aug; 12(8):786. PubMed ID: 34381017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells.
    Ko JC; Chen HJ; Huang YC; Tseng SC; Weng SH; Wo TY; Huang YJ; Chiu HC; Tsai MS; Chiou RY; Lin YW
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):415-24. PubMed ID: 23069143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1 Mutation: A Predictive Marker for Radiation Therapy?
    Kan C; Zhang J
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):281-93. PubMed ID: 26383678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of chromatid-break-repair detects a homologous recombination to non-homologous end-joining switch with increasing load of DNA double-strand breaks.
    Murmann-Konda T; Soni A; Stuschke M; Iliakis G
    Mutat Res Genet Toxicol Environ Mutagen; 2021 Jul; 867():503372. PubMed ID: 34266628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
    Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
    Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polo-like kinase 1 mediates BRCA1 phosphorylation and recruitment at DNA double-strand breaks.
    Chabalier-Taste C; Brichese L; Racca C; Canitrot Y; Calsou P; Larminat F
    Oncotarget; 2016 Jan; 7(3):2269-83. PubMed ID: 26745677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining.
    Lee Y; Li HK; Masaoka A; Sunada S; Hirakawa H; Fujimori A; Nickoloff JA; Okayasu R
    Radiother Oncol; 2016 Oct; 121(1):162-168. PubMed ID: 27666928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FANCJ compensates for RAP80 deficiency and suppresses genomic instability induced by interstrand cross-links.
    Awate S; Sommers JA; Datta A; Nayak S; Bellani MA; Yang O; Dunn CA; Nicolae CM; Moldovan GL; Seidman MM; Cantor SB; Brosh RM
    Nucleic Acids Res; 2020 Sep; 48(16):9161-9180. PubMed ID: 32797166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer.
    Mansour WY; Tennstedt P; Volquardsen J; Oing C; Kluth M; Hube-Magg C; Borgmann K; Simon R; Petersen C; Dikomey E; Rothkamm K
    Sci Rep; 2018 Mar; 8(1):3947. PubMed ID: 29500400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.
    Vollebergh MA; Jonkers J; Linn SC
    Cell Mol Life Sci; 2012 Jan; 69(2):223-45. PubMed ID: 21922196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells.
    Ha K; Fiskus W; Choi DS; Bhaskara S; Cerchietti L; Devaraj SG; Shah B; Sharma S; Chang JC; Melnick AM; Hiebert S; Bhalla KN
    Oncotarget; 2014 Jul; 5(14):5637-50. PubMed ID: 25026298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.
    Ohba S; Hirose Y; Yoshida K; Yazaki T; Kawase T
    J Neurosurg; 2010 Jan; 112(1):33-42. PubMed ID: 19408974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells.
    Noordermeer SM; van Attikum H
    Trends Cell Biol; 2019 Oct; 29(10):820-834. PubMed ID: 31421928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair.
    Ashworth A
    J Clin Oncol; 2008 Aug; 26(22):3785-90. PubMed ID: 18591545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.